DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 215 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,388 | +10.6% | 22,572 | -3.3% | 0.00% | +33.3% |
| Q2 2023 | $301,540 | +25.8% | 23,339 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $239,707 | -9.4% | 24,435 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $264,574 | +8.4% | 24,866 | +6.3% | 0.00% | 0.0% |
| Q3 2022 | $244,000 | -1.6% | 23,401 | +18.6% | 0.00% | 0.0% |
| Q2 2022 | $248,000 | -22.3% | 19,729 | -9.9% | 0.00% | -57.1% |
| Q2 2016 | $319,000 | -24.2% | 21,900 | 0.0% | 0.01% | -22.2% |
| Q1 2016 | $421,000 | -20.9% | 21,900 | -0.5% | 0.01% | -25.0% |
| Q4 2015 | $532,000 | – | 22,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |